Prognostic Factors in Patients Receiving An Allogeneic Stem Cell Transplantation for Relapsed AML. Results of the Prospective AML 295 and 01/99 Studies

被引：0
|
作者：
Krauter, Juergen [1 ]
Heil, Gerhard [2 ]
Hoelzer, Dieter [3 ]
Martin, Hans [3 ]
Ottmann, Oliver G. [3 ]
Finke, Juergen [4 ]
Luebbert, Michael [5 ]
Heit, Wolfgang [6 ]
Fiedler, Walter [7 ]
Kanz, Lothar [8 ]
Schlimok, Guenter [9 ]
Kirchner, Hartmut [10 ]
Raghavachar, Aruna [11 ]
Brugger, Wolfram [12 ]
Doehner, Hartmut [13 ]
Ganser, Arnold [1 ]
机构：
[1] Hannover Med Sch, Dept Hematol Hemostaseol Oncol & Stem Cell Transp, D-3000 Hannover, Germany
[2] Krankenhaus Ludenscheid, Ludenscheid, Germany
[3] JW Goethe Univ Hosp, Frankfurt, Germany
[4] Univ Med Ctr Freiburg, Freiburg, Germany
[5] Univ Freiburg, Med Ctr, D-7800 Freiburg, Germany
[6] Kliniken Essen Sud, Essen, Germany
[7] Univ Hosp Eppendorf, Dept Hematol & Oncol, Hamburg, Germany
[8] Univ Tubingen, Tubingen, Germany
[9] Klinikum Augsburg, Med Klin 2, Augsburg, Germany
[10] Klinik Hannover, Hannover, Germany
[11] HELIOS Klinikum Wuppertal, Med Klin 1, Wuppertal, Germany
[12] Hosp Villingen Schwenningen, Schwenningen, Germany
[13] Univ Ulm, Ulm, Germany
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [31] Allogeneic stem cell transplantation for patients with AML and FLT-3 mutations
    Schleuning, M.
    Judith, D.
    Heshmat, M.
    Burlakova, I.
    Tschischka, S.
    Baurmann, H.
    Schwerdtfeger, R.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S274 - S275
  • [32] Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma
    Shimizu, H.
    Saitoh, T.
    Tanaka, M.
    Mori, T.
    Sakura, T.
    Kawai, N.
    Kanda, Y.
    Nakaseko, C.
    Yano, S.
    Fujita, H.
    Fujisawa, S.
    Miyawaki, S.
    Kanamori, H.
    Okamoto, S.
    LEUKEMIA, 2012, 26 (12) : 2469 - 2473
  • [33] Allogeneic Hematopoietic Stem Cell Transplantation for Adult AML Patients with Granulocytic Sarcoma
    Shimizu, Hiroaki
    Saitoh, Takayuki
    Tanaka, Masatsugu
    Mori, Takehiko
    Kawai, Nobutaka
    Sakura, Toru
    Kanda, Yoshinobu
    Nakaseko, Chiaki
    Yano, Shingo
    Fujita, Hiroyuki
    Fujisawa, Shin
    Miyawaki, Shuichi
    Kanamori, Heiwa
    Okamoto, Shinichiro
    BLOOD, 2011, 118 (21) : 890 - 891
  • [34] 5-azacitidine is a possible therapeutic option for patients with relapsed AML or MDS after allogeneic stem cell transplantation
    Steckel, N. K.
    Gromke, T.
    Hegerfeldt, Y.
    Hlinka, M.
    Koldehoff, M.
    Ditschkowski, M.
    Elmaagacli, A.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S540 - S541
  • [35] Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)
    Siddhartha Ganguly
    Manik Amin
    Clint Divine
    Omar S. Aljitawi
    Sunil Abhyankar
    Joseph P. McGuirk
    Annals of Hematology, 2013, 92 : 549 - 550
  • [36] Outcome of myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation for refractory/relapsed AML patients in NR status
    Liu, Na
    Ning, Hong-Mei
    Hu, Liang-ding
    Jiang, Min
    Xu, Chen
    Hu, Jiang-Wei
    Wang, Jun
    Li, Yu-Hang
    Li, Bo-tao
    Lou, Xiao
    Yang, Fan
    Chen, Jian-Lin
    Su, Yong-Feng
    Li, Meng
    Wang, Hong-ye
    Ren, Jing
    Feng, Yue-Qian
    Zhang, Bin
    Wang, Dan-hong
    Chen, Hu
    LEUKEMIA RESEARCH, 2015, 39 (12) : 1375 - 1381
  • [37] Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)
    Ganguly, Siddhartha
    Amin, Manik
    Divine, Clint
    Aljitawi, Omar S.
    Abhyankar, Sunil
    McGuirk, Joseph P.
    ANNALS OF HEMATOLOGY, 2013, 92 (04) : 549 - 550
  • [38] Allogeneic stem cell transplantation with reduced-intensity conditionning regimen for adult patients with AML: same results in secondary and de novo AML
    Tabrizi, R.
    Guillaume, T.
    Pigneux, A.
    Chevallier, P.
    Boiron, J. M.
    Moreau, P.
    Mahe, B.
    Leguay, T.
    Bouabdallah, K.
    Morineau, N.
    Delaunay, J.
    Melot, C.
    Saulquin, B.
    Marit, G.
    Harousseau, J. -L.
    Milpied, N. J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S38 - S39
  • [39] Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
    Jentzsch, Madlen
    Bischof, Lara
    Ussmann, Jule
    Backhaus, Donata
    Brauer, Dominic
    Metzeler, Klaus H. H.
    Merz, Maximilian
    Vucinic, Vladan
    Franke, Georg-Nikolaus
    Herling, Marco
    Platzbecker, Uwe
    Schwind, Sebastian
    BLOOD CANCER JOURNAL, 2022, 12 (12):
  • [40] Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
    Madlen Jentzsch
    Lara Bischof
    Jule Ussmann
    Donata Backhaus
    Dominic Brauer
    Klaus H. Metzeler
    Maximilian Merz
    Vladan Vucinic
    Georg-Nikolaus Franke
    Marco Herling
    Uwe Platzbecker
    Sebastian Schwind
    Blood Cancer Journal, 12
12345